Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2000
06/06/2000CA1341015C Outer membrane protein f of pseudomonas aeruginosa
06/06/2000CA1341014C Hcg peptides for use in antibody purification procedures
06/06/2000CA1341013C Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells
06/06/2000CA1341012C Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides
06/02/2000WO2000031547A1 Prion protein standard and method of making same
06/02/2000WO2000031546A1 Antibodies to peptides that target git receptors and related methods
06/02/2000WO2000031545A1 Diagnosis of demyelinating or spongiform disease
06/02/2000WO2000031533A1 Test kit and method of diagnosing severe acute pancreatitis
06/02/2000WO2000031532A1 Methods of identifying viral therapeutics
06/02/2000WO2000031286A1 Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods
06/02/2000WO2000031285A1 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
06/02/2000WO2000031284A1 Protein expression vector and utilization thereof
06/02/2000WO2000031283A2 Regulatory sequences useful for gene expression in plant embryo tissue
06/02/2000WO2000031281A2 Dna sequence encoding a glutamate/malate translocator, plasmids, bacteria, yeasts and plants containing said transporter
06/02/2000WO2000031279A2 Producing antimicrobial cationic peptides as fusion proteins
06/02/2000WO2000031270A1 Bartonella proteins and uses thereof
06/02/2000WO2000031269A2 Plant cell proliferation-associated proteins
06/02/2000WO2000031268A1 Maize rad23 genes and uses thereof
06/02/2000WO2000031266A1 Human parathyroid hormone modifications, preparation and use
06/02/2000WO2000031265A1 Urotensins ii of mammals and their uses
06/02/2000WO2000031264A2 Testis-specific cystatin-like protein cystatin t
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031262A2 Human neurotensin subtype 2 receptor
06/02/2000WO2000031261A2 Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor
06/02/2000WO2000031260A1 Testis specific glycoprotein zpep10
06/02/2000WO2000031259A1 Mammalian secretory protein zsig43
06/02/2000WO2000031258A2 Human orphan g protein-coupled receptors
06/02/2000WO2000031256A1 Novel gene encoding brain-specific membrane protein
06/02/2000WO2000031255A1 Novel ubiquitin-like protein
06/02/2000WO2000031254A2 Apoptosis-inducing factor
06/02/2000WO2000031253A2 Mutation of the parkin gene, compositions, methods and uses
06/02/2000WO2000031252A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
06/02/2000WO2000031249A1 Root-preferred promoters and their use
06/02/2000WO2000031248A1 Humanized monoclonal antibodies
06/02/2000WO2000031240A1 Immortalized brain endothelial cells
06/02/2000WO2000031239A1 Immune cells having predefined biological specificity, comprising chimeric t cell receptor
06/02/2000WO2000031235A2 Nucleotide and protein sequences of nogo genes and methods based thereon
06/02/2000WO2000031142A2 Plant syr2 homologs
06/02/2000WO2000031140A1 Inhibitor of metalocarboxypeptidases as fibrinolytic agent
06/02/2000WO2000031139A1 Peptide inhibitor of browman-birk type
06/02/2000WO2000031138A1 Membrane antigenic structure inducing stoppage of proliferation and apoptosis of activated t-lymphocytes
06/02/2000WO2000031137A1 Amino-terminal modified parathyroid hormone (pth) analogs
06/02/2000WO2000031136A1 Antagonistic analogs of gh-rh inhibiting igf-i and -ii
06/02/2000WO2000031135A1 TGF$G(b)1 INHIBITOR PEPTIDES
06/02/2000WO2000031133A2 Potassium channel interactors and uses therefor
06/02/2000WO2000031132A1 Novel polypeptide
06/02/2000WO2000031131A1 Peptide fragments having cell death inhibitory activity
06/02/2000WO2000031130A1 Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
06/02/2000WO2000031129A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease
06/02/2000WO2000031128A1 Chimeric biotin-binding papillomavirus protein
06/02/2000WO2000031127A2 Protein fragments for use in protein targeting
06/02/2000WO2000031126A2 Suppression of xenotransplant rejection
06/02/2000WO2000031125A2 REGULATORY PROTEIN pKe#83 FROM HUMAN KERATINOCYTES
06/02/2000WO2000031124A2 Peptides that modulate the interaction of b class ephrins and pdz domains
06/02/2000WO2000031123A2 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
06/02/2000WO2000031122A1 Hydrophilic somatostatin analogs
06/02/2000WO2000031121A1 Recombinant factor viii binding peptides
06/02/2000WO2000031116A1 Method for continuously isolating active proteins
06/02/2000WO2000031115A1 Methods of identifying antigen gene sequences
06/02/2000WO2000031114A1 DNA ENCODING PROTEINS THAT INHIBIT Hsp70 FUNCTION
06/02/2000WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN
06/02/2000WO2000031108A1 Dna molecules encoding hg51, a g-protein-coupled receptor
06/02/2000WO2000031107A1 7tm receptor hlwar77
06/02/2000WO2000031104A1 A novel g-protein coupled 7tm receptor (axor15)
06/02/2000WO2000030687A1 Novel adenoviral vector and methods for making and using the same
06/02/2000WO2000030680A1 Tumor antigen-specific antibody-gp39 chimeric protein constructs
06/02/2000WO2000030672A1 Collagen based biomaterials and methods of preparation and use
06/02/2000WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000WO2000030667A2 Compositions and methods using lactadherin or variants thereof
06/02/2000WO2000030662A1 Fabz
06/02/2000WO2000030590A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
06/02/2000WO2000030587A2 NF-λB ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES
06/02/2000WO2000030454A1 Compositions and methods using cell fusion
06/02/2000WO2000030453A2 Insecticidal agents
06/02/2000WO2000030437A1 Transgenic animals
06/02/2000WO2000030436A1 Stabilisation of milk from transgenic animals
06/02/2000WO2000016061A3 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates
06/02/2000WO2000015774A9 Useful properties of a bee venom protein and gene encoding same
06/02/2000WO2000014244A3 Treatment of cervical cancer
06/02/2000WO2000014236A3 Grf analogs with increased biological potency
06/02/2000WO2000012716A3 MAIZE Ku70 ORTHOLOGUE AND USES THEREOF
06/02/2000WO2000012545A3 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
06/02/2000WO2000012128A8 Recombinant subunit vaccine against flaviviral infection
06/02/2000WO2000011185A3 Improved expression of cry3b insecticidal protein in plants
06/02/2000WO2000011178A3 An antifungal protein from tall fescue and its use in plant disease control
06/02/2000WO2000011148A9 Cold-shock regulatory elements, constructs thereof, and methods of use
06/02/2000WO2000011141A3 Trna binding domain
06/02/2000WO2000011030A3 Method for chromatographically purifying insulins
06/02/2000WO2000009526A3 Method for dpc4 (smad4) nuclear localization
06/02/2000WO2000009156A9 Non-virulent porphyromonas gingivalis mutant
06/02/2000WO2000008131A3 Pseudotyped retroviruses and stable cell lines for their production
06/02/2000WO2000008045A3 Novel molecules of the tango-93-related protein family and uses thereof
06/02/2000WO2000007610A8 Interacting proteins for autoantigens of autoimmune diseases
06/02/2000WO2000003024A9 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon
06/02/2000WO1999064594A8 Genes and gene expression products that are differentially regulated in prostate cancer
06/02/2000WO1999063095A9 Nucleic acid vaccines for prevention of flavivirus infection
06/02/2000WO1999062942A3 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
06/02/2000WO1999054446A3 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
06/02/2000CA2645717A1 Human orphan g protein-coupled receptors
06/02/2000CA2369706A1 Testis specific glycoprotein zpep10
1 ... 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 ... 2916